Brenda Medina BBA

Brenda Medina is a dynamic, innovative leader in the pharmaceutical industry. She has upwards of 20 years of clinical business and technology operations experience. Currently, Brenda is the VP, Tech Delivery and Vendor Operations at Medidata Dassault Systèmes where her main responsibility includes the oversight and alignment of the R&D strategic pillars to the execution, integration and operations of the 3DS India teams assigned to R&D. She has been at Medidata since September 2020.

Most recently, Brenda was the Sr. Director of Business Operations at Nektar Therapeutics, Inc. She led a team, strategy and execution for the Site Contract Negotiations and the Vendor Outsourcing Department.

Before Nektar, Brenda was the Director, Development Science Business Operations for BioMarin Pharmaceuticals. She led a team, strategy and execution of the Site Budget Feasibility, Creation, Negotiation, Payments, Outsourcing, Contracts, Vendor Management and Reporting Department. While at BioMarin, she also established the Analytics Department and Portfolio Planning  for Financial Management of clinical trials function. Just like at Eisai, she led the development and implementation of an analytics platform that integrated operations and financial data, including all the clinical system integrations.

She is a clinical business and technology expert. She has developed the process and tools for the study budget management process, site feasibility, and oversight, including investigator benchmarking, FMV, budget negotiations, reconciliation and aggregate  spend  reporting. In all her roles, Brenda has been the lead to some significant projects that commenced with data analytics and the utilization of financial metrics for the improvement of the overall operational clinical development life cycle.